New compound increases strength of antidote for fentanyl and other lethal drugs
New agreement hands UK drugmaker control of developing jabs and provides cash injection for German group
Federal health officials step up efforts to boost jab stockpiles in response to widening outbreak
Neurotech advance gives patients in MIT study walking speed and control closer to people who had not lost limbs
Information about patients remains ‘liquid gold’ when it comes to enriching medical research
Pharma group dealt another blow following decision by British to award vaccine contract to rival Pfizer
Discovery could allow more precise and efficient targeting of DNA modifications
Oral formulation offers prospect of cheaper and more convenient access to drug, research suggests
Researchers are trying to tackle the threat before nature’s ‘flying needles’ become more prevalent and resistant to prevention
Innovation prize targeting urinary tract infections boosts effort to tackle pathogens that develop immunity to drugs
Health authorities move to protect farmworkers and other high-risk groups after recent outbreaks
Vaccine maker to seek approval for jab as it tries to diversify product pipeline
Launch highlights growth of venture philanthropy to boost search for treatments and cures
As incidence rises, breakthroughs in oncology show the value of research funding
‘Gene desert’ research boosts knowledge of chronic disease mechanisms and promises to unlock novel therapies
Radical advances in neurotechnology are helping disabled people walk and could provide the link between human and artificial intelligence
Experts warn that epidemics of the mosquito-born virus will become more common as a result of climate change
The writer and campaigner on love, last wishes and the divisive debate over assisted dying
Funding would help to bolster stockpile as CDC reports third dairy worker infected
As Covid revenues slump, technology developed to fight the pandemic is having some success combating this disease
Fears of growing outbreak drive revival in vaccine group stocks which have been out of favour since pandemic ended
Brian Langstaff’s long-awaited report found failures by government departments and various parts of NHS
Clinical study shows better hand and arm function after using non-invasive device to stimulate spinal cord
So-called FLiRT strains set to test effectiveness of vaccines against latest mutations
Findings on ‘metabolic risk factors’ reflect shift in biggest threats since start of 21st century
UK Edition
